Pharmacokinetics of ABT-494 with the Once-Daily Extended-Release Tablet Formulation Being Utilized in the Ongoing Rheumatoid Arthritis Phase 3 Trials

被引：0
|
作者：
Mohamed, Mohamed-Eslam [1 ]
Zeng, Jiewei [2 ]
Song, In-Ho [2 ]
Othman, Ahmed A. [2 ]
机构：
[1] AbbVie, Clin Pharmacol & Pharmacometr, N Chicago, IL USA
[2] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1629
引用
收藏
页数：2
相关论文
共 25 条
  • [21] Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I-III Clinical Trials
    Klunder, Ben
    Mittapalli, Rajendar K.
    Mohamed, Mohamed-Eslam F.
    Friedel, Anna
    Noertersheuser, Peter
    Othman, Ahmed A.
    CLINICAL PHARMACOKINETICS, 2019, 58 (08) : 1045 - 1058
  • [22] Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study
    Yu, Shiying
    Shen, Wei
    Yu, Lu
    Hou, Yanyan
    Han, John
    Richards, Henry M.
    JOURNAL OF PAIN, 2014, 15 (08): : 835 - 844
  • [23] Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
    Rostaing, Lionel
    Bunnapradist, Suphamai
    Grinyo, Josep M.
    Ciechanowski, Kazimierz
    Denny, Jason E.
    Silva, Helio Tedesco, Jr.
    Budde, Klemens
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (04) : 648 - 659
  • [24] A Randomized Cross-Over Phase 3b Study of the Pharmacokinetics of Once-Daily Extended Release MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus in African-Americans (ASERTAA)
    Trofe-Clark, J.
    Brennan, D.
    West-Thielke, P.
    Milone, M.
    Lim, M.
    Bloom, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [25] Baricitinib 4mg and 2mg Once-Daily Reduced Pain in Both Patients Who Were Opioid Users and Non-users in Active Rheumatoid Arthritis: A Post-hoc Analysis of Phase 3 Trials
    Pope, Janet
    Lee, Yvonne
    Curtis, Jeffrey
    Mo, Daojun
    Rooney, Terence
    Xie, Li
    Dickson, Christina
    Schlichting, Douglas
    Quebe, Amanda
    Cardoso, Anabela
    Simon, Lee
    Taylor, Peter
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1129 - 1130
123